Vimarsana
Biggest News Aggregation in the World

Page 2 - Lab Diagnostics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Lab Diagnostics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Lab Diagnostics Today - Breaking & Trending Today

Q-linea's partner Pro-Lab Diagnostics starts its first commercial evaluation in the UK - Vimarsana News

Q-linea's partner Pro-Lab Diagnostics starts its first commercial evaluation in the UK

Q-linea AB today announces that its appointed distributor for UK, Pro-Lab Diagnostic have started their first commercial evaluation at a large regional hospital in the Southwest of the UK. The site... | May 23, 2023

Q-linea Q1 - Building a launch platform during 2023 - Vimarsana News

Q-linea Q1 - Building a launch platform during 2023

Q-linea is in a transition period after the break with Thermo Fisher, and in Q1 there are no reported sales. Q-linea has decided on a cost-saving program and has a targeted regional sales strategy in... | May 8, 2023

Global E. Coli Testing Strategic Business Report 2023: - Vimarsana News

Global E. Coli Testing Strategic Business Report 2023:

Dublin, April 20, 2023 (GLOBE NEWSWIRE) -- The "E. Coli Testing - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's...

The origin of congenital coronary fistulae discovered - Vimarsana News

The origin of congenital coronary fistulae discovered

Scientists of the Department of Animal Biology of the University of Malaga have discovered the cellular mechanism that originates coronary arterio-ventricular fistulae, a congenital anomaly that, in severe cases, may result in death.

Newly identified small molecule may help treat people with drug-resistant epilepsy - Vimarsana News

Newly identified small molecule may help treat people with drug-resistant epilepsy

Researchers at Tufts University School of Medicine and colleagues have identified a small molecule that may help treat people with epilepsy whose condition has become resistant to the benzodiazepine drugs usually used in managing seizures.